Establishes a drug-induced movement disorder screening education program; provides that the department shall develop such program to educate the public about the importance of screening for drug-induced movement disorders, develop and disseminate educational materials for healthcare providers regarding treatment for drug-induced movement disorders, and eliminate bias and reduction of stigma for people living with drug-induced movement disorders related to the treatment of mental health conditions.
STATE OF NEW YORK
________________________________________________________________________
6799--B
2023-2024 Regular Sessions
IN ASSEMBLY
May 8, 2023
___________
Introduced by M. of A. PAULIN, SAYEGH, SEAWRIGHT -- read once and
referred to the Committee on Health -- committee discharged, bill
amended, ordered reprinted as amended and recommitted to said commit-
tee -- recommitted to the Committee on Health in accordance with
Assembly Rule 3, sec. 2 -- committee discharged, bill amended, ordered
reprinted as amended and recommitted to said committee
AN ACT to amend the public health law, in relation to establishing a
drug-induced movement disorder screening education program
The People of the State of New York, represented in Senate and Assem-bly, do enact as follows:
1 Section 1. Subdivision 1 of section 207 of the public health law is
2 amended by adding a new paragraph (h) to read as follows:
3 (h) The department shall develop and conduct a program concerning
4 drug-induced movement disorders. Such program shall include but not be
5 limited to, (i) educational information on the importance of screening
6 for and identifying symptoms of drug-induced movement disorders; and
7 (ii) the development and dissemination of educational materials for
8 healthcare providers regarding treatment for drug-induced movement
9 disorders, including for services provided via telehealth. Such educa-
10 tional materials disseminated to healthcare providers shall be developed
11 and disseminated in coordination with relevant healthcare provider
12 groups and shall include best practices for the treatment and screening
13 of movement disorders informed by the American Psychiatric Association
14 and other professional society practice guidelines. Such program shall
15 also include education and outreach on the elimination of stigma for
16 people living with drug-induced movement disorders related to the treat-
17 ment of mental health conditions.
18 § 2. This act shall take effect on the ninetieth day after it shall
19 have become a law. Effective immediately, the addition, amendment and/or
20 repeal of any rule or regulation necessary for the implementation of
21 this act on its effective date are authorized to be made and completed
22 on or before such effective date.
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[] is old law to be omitted.
LBD10964-05-4
